With a global increase in public scrutiny on price and accessibility of pharmaceuticals, the main focus will be on bringing down pharmaceutical prices. This will accelerate the release of generic and biosimilar versions of branded drugs to the market thereby shattering the long-standing pricing models for the drug developers. In order to preserve profitability, native pharmaceutical companies are expected to increase the use of outsourced partners to drive down costs. Only sales and R&D are likely to remain in-house concerns with all other critical operations being outsourced. As a result, more and more alliances are expected between packaging, transportation, and contract manufacturing providers in order to leverage best-in-class capabilities for supporting the increasing rate of cost-conscious global pharmaceutical companies. That’s where pharmaceutical companies from countries like India can contribute to the pharmaceutical industry in USA. These Indian companies get ample supply of low-cost raw materials and skilled workforce which enables them to export the best quality medicines at the most competitive prices. Alliances with Indian pharmaceutical exporters can release the burden of manufacturing on American companies to a great extent which will enable them to focus on other key aspects in the supply chain. If you are looking to tie up with reputed Indian pharmaceutical manufacturers then you can feel free to contact us.